Femasys, Inc. (FEMY)
2.96
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
2.90
-0.06
(-2.03%)
After-Hours: 20:00
Femasys Max Drawdown (5Y) : 98.40% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 98.40% |
| June 30, 2026 | 98.40% |
| May 31, 2026 | 97.45% |
| April 30, 2026 | 97.45% |
| March 31, 2026 | 97.45% |
| February 28, 2026 | 97.45% |
| January 31, 2026 | 97.45% |
| Date | Value |
|---|---|
| December 31, 2025 | 97.45% |
| November 30, 2025 | 97.45% |
| October 31, 2025 | 97.45% |
| September 30, 2025 | 97.45% |
| August 31, 2025 | 97.45% |
| July 31, 2025 | 97.45% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Abbott Laboratories | 39.63% |
| AngioDynamics, Inc. | 82.98% |
| Alphatec Holdings, Inc. | 73.51% |
| AtriCure, Inc. | 77.21% |
| Baxter International, Inc. | 80.60% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -38.96 |
| Beta (5Y) | -2.081 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 191.0% |
| Historical Sharpe Ratio (5Y) | -0.3043 |
| Historical Sortino (5Y) | -1.273 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 38.75% |